FDA Inspection 1091698 — Cambrex Profarmaco Milano Srl

Cambrex Profarmaco Milano Srl — FEI 3003723076

The FDA completed an inspection of Cambrex Profarmaco Milano Srl on May 7, 2019 in Paullo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 7, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paullo (Italy)